Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qishe Medicinal Liquor is a Traditional Chinese Medicine (TCM) liquid formulation manufactured and marketed by Universe Pharmaceuticals (through its subsidiary Jiangxi Nature Pharmaceutical) under the brand name Hu Zhuo Ren. It is registered in China under the approval number 国药准字Z36020910. The medicinal liquor is formulated with several traditional ingredients, including *Agkistrodon acutus* (蕲蛇/five-pacer viper), Carthamus tinctorius (红花), Angelica sinensis (当归), Cortex Periplocae (香加皮), Gentiana macrophylla (秦艽), Saposhnikovia divaricate (防风), and Notopterygium incisum (羌活). It is indicated for dispelling wind, removing dampness, promoting blood circulation, and dredging collaterals, and is primarily used to treat joint pain, rheumatic bone pain, and numbness of limbs in elderly patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qishe Medicinal Liquor.